Mineralys Therapeutics EPS MLYS

Diluted earnings per share by quarter and over the last twelve months, from 2022.

Mineralys Therapeutics' earnings per share was −$4.24 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$2.85.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$2.85	n/a	−$4.24
Q1 FY26	Mar 31, 2026	−$0.47	n/a	−$2.05
Q4 FY25	Dec 31, 2025	−$0.40	n/a	−$2.37
Q3 FY25	Sep 30, 2025	−$0.52	n/a	−$2.95
Q2 FY25	Jun 30, 2025	−$0.66	n/a	−$3.56
Q1 FY25	Mar 31, 2025	−$0.79	n/a	−$3.73
Q4 FY24	Dec 31, 2024	−$0.98	n/a	−$3.64
Q3 FY24	Sep 30, 2024	−$1.13	n/a	−$3.27
Q2 FY24	Jun 30, 2024	−$0.83	n/a	−$2.71
Q1 FY24	Mar 31, 2024	−$0.70	n/a	−$2.19
Q4 FY23	Dec 31, 2023	−$0.61	n/a	−$2.00
Q3 FY23	Sep 30, 2023	−$0.57	n/a	−$3.13

Companies in Drug Manufacturers - General nearest Mineralys Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
MLYSMineralys Therapeutics	−$4.24
ANIPANI Pharmaceuticals	$4.70
PAHCPhibro Animal Health	$2.44	+107% a year
HRMYHarmony Biosciences	$3.09	−0% a year
PBHPrestige Consumer Healthcare	$3.57	−16% a year
ANABAnaptysbio	$4.57
PCRXPacira BioSciences	$0.35
OMEROmeros	$1.52
NRIXNurix Therapeutics	$2.31
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OGNOrganon	$0.77	−71% a year
Peer median	$2.38